cbm 4a has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bieblová, J; Indrová, M; Jandlová, T; Pajtasz-Piasecka, E; Reinis, M; Vonka, V | 1 |
1 other study(ies) available for cbm 4a and Disease Models, Animal
Article | Year |
---|---|
Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
Topics: Animals; Cancer Vaccines; Disease Models, Animal; Down-Regulation; Genes, MHC Class I; Genetic Therapy; HLA Antigens; Human papillomavirus 16; Humans; Ifosfamide; Immunotherapy; Interleukin-12; Male; Mice; Neoplasm, Residual; Neoplasms, Experimental; Tumor Cells, Cultured; Up-Regulation | 2006 |